Bepotastine besilate

베포타스틴베실산염

KDMF APIs알레르기KDMF 등록
품목명 (영문)
Bepotastine besilate
품목명 (한글)
베포타스틴베실산염
분류
알레르기
CAS No.
125602-71-3
KDMF 등록번호
20190926-209-J-357
제조원
Bal Pharma Limited
규격
JP
IUPAC Name
4-{4-[(4-chlorophenyl)(pyridin-2-yl)methoxy]piperidin-1-yl}butanoic acid
Description
Bepotastine is a non-sedating, selective antagonist of the histamine 1 (H1) receptor. Bepotastine was approved in Japan for use in the treatment of allergic rhinitis and uriticaria/puritus in July 2000 and January 2002, respectively, and is marketed by Tanabe Seiyaku Co., Ltd. under the brand name Talion. It is available in oral and opthalmic dosage forms in Japan. The opthalmic solution is FDA approved since Sept 8, 2009 and is under the brand name Bepreve.
Certificate of Analysis
If you need more information, please contact us.
이 원료 견적 요청목록으로

규격서·시험성적서 등 추가 자료가 필요하시면 문의 시 함께 요청해 주세요. 담당자가 확인 후 회신합니다. (02-579-1056 · ace@acebiopharm.com)

문의하기